Why disabled young people with life-shortening conditions need better support for intimacy
Until relatively recently, children and young people with life-shortening conditions were not expected to survive into adulthood.
Jan 7, 2026
0
9
MeSH tree: C05.651.534
Until relatively recently, children and young people with life-shortening conditions were not expected to survive into adulthood.
Jan 7, 2026
0
9
Wearing masks, avoiding large gatherings, shutting down schools—those scenes might sound familiar to anyone who experienced the most recent global pandemic.
Dec 8, 2025
0
11
At the cellular level, the mechanics of how muscle tissue repair occurs gets complicated. There are significant differences between, say, tearing a muscle in a sports injury versus muscle tissue wasting away from diseases ...
Nov 21, 2025
0
42
The United States on Friday said it would add its most serious warning label to a gene therapy treatment for a debilitating muscle-wasting disease, and also limit its approved use.
Nov 15, 2025
0
16
Because researchers have made such striking progress in developing drugs to treat neuromuscular diseases, Scott Delp, Ph.D., was surprised to learn that scientists conducting clinical trials were still relying on a decidedly ...
Nov 4, 2025
0
13
If cancer is a disease of overabundance, where cells divide without restraint and tumors grow despite the body's best interests, then degenerative diseases are disorders of deprivation. When malfunctions occur in the biological ...
Oct 30, 2025
0
14
Faulty versions of the LMNA gene can cause a wide range of health problems, including heart muscle disease (dilated cardiomyopathy) and muscle weakness (muscular dystrophies). Many of these diseases are caused by single-point ...
Every movement we make, whether walking, speaking or even breathing, depends on the health of our muscles and nerves.
Sep 19, 2025
0
21
FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency's decisions from public scrutiny.
Sep 15, 2025
0
12
A study conducted by the University of Eastern Finland and Fimea found that the Finnish news media has given GLP-1 agonists used to treat obesity, such as semaglutide, a great deal of attention while many other new medicines ...
Sep 10, 2025
0
8